Lubricant

Abstract Aims: Different types of drug release modifying polymers, their grades and quantities have to be optimised in the formulation considering...

Abstract Objectives: The current study presents a sequential strategy for the development of directly compressible powder formulations relying on Design...

Proven effectiveness meets convincing properties and versatile applications: SOFTISAN® 378 has demonstrated its value for more than 30 years now....

Introduction Magnesium stearate (MgSt) is a common lubricant that is added to tablet formulations to reduce the friction between granules...

Abstract Successful development of direct-compression formulations can be hindered by poor compactibility of active pharmaceutical ingredients active pharmaceutical ingredients (APIs),...

Formulation Challenges in Low-Dose Fixed-Dose Combinations Developing fixed-dose combination (FDC) therapies presents unique formulation challenges, particularly when one active pharmaceutical...

Abstract The Knowledge-Aided Assessment and Structured Application (KASA) is an initiative led by the FDA’s Center for Drug Evaluation and...

A new model was developed to predict the tensile strength of tablets compressed from a lubricated dry powder blend by...

Press Release | November 18, 2025 SHANGHAI, China, Nov. 18, 2025 — DuPont (NYSE: DD) today held a groundbreaking ceremony for...

Inertness Compritol® 888 ATO is inert Compritol® 888 ATO - glyceryl dibehenate - does not react with active pharmaceutical ingredients...